HPM
NVO

Hudson Portfolio Management’s Novo Nordisk NVO Stock Holding History

Hudson Portfolio Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
+5,415
New +$233K 0.2% 105
2026
Q1 		– Sell
-5,415
Closed -$276K – 112
2025
Q4 		$276K Hold
5,415
– – 0.24% 97
2025
Q3 		$300K Buy
+5,415
New +$317K 0.27% 90

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hudson Portfolio Management's NVO Position: Q2 2026 in Review

Hudson Portfolio Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 5,415 shares worth $260K. The stake represents 0.2% of the portfolio and ranks #105 among its holdings. This is a return to the name: Hudson Portfolio Management previously reported a position in NVO as recently as Q4 2025.

Hudson Portfolio Management first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $300K in Q3 2025. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hudson Portfolio Management held 5,415 shares of Novo Nordisk worth $260K as of Q2 2026.
  • Novo Nordisk was a new Hudson Portfolio Management position in Q2 2026.
  • Novo Nordisk made up 0.2% of Hudson Portfolio Management's portfolio in Q2 2026, its #105 holding.
  • Hudson Portfolio Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • Hudson Portfolio Management's Novo Nordisk position peaked at $300K in Q3 2025.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hudson Portfolio Management's 13F filing for Q2 2026, filed 12 Aug 2026.